(Q33812436)

29 July 2017

title

Cost effectiveness analysis in health care: contraindications (English)

1 reference

cost-effectiveness analysis

29 July 2017

main subject

1 reference

1 reference

Cam Donaldson

1

1 reference

29 July 2017

Gillian Currie

series ordinal

2

1 reference

29 July 2017

Craig Mitton

series ordinal

3

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

29 July 2017

1 reference

29 July 2017

volume

325

1 reference

29 July 2017

issue

7369

1 reference

29 July 2017

page(s)

891-894

1 reference

Twenty years of health care economic analysis in Spain: are we doing well?

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Developing guidance for budget impact analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

The quality of reporting in published cost-utility analyses, 1976-1997.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Cost effectiveness analysis of screening for sight threatening diabetic eye disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Cost utility analysis of sildenafil compared with papaverine-phentolamine injections

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Two view mammography at incident screens: cost effectiveness analysis of policy options

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Economics notes: types of economic evaluation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Economic evaluation in health care: is there a role for cost-benefit analysis?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

What Do We Gain from the Sixth Stool Guaiac?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

The cost effectiveness of combination antiretroviral therapy for HIV disease.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Cost-effectiveness of colonoscopy in screening for colorectal cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Cost Effectiveness of Early Discharge after Uncomplicated Acute Myocardial Infarction

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1124387

Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance

30 October 2018

1 reference

12 December 2020

Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis

1 reference

12 December 2020

The influence of economic evaluation studies on decision making. A European survey. The EUROMET group

1 reference

12 December 2020

Barriers to using cost-effectiveness analysis in managed care decision making

1 reference

12 December 2020

Cost-effectiveness analysis under managed care: not yet ready for prime time?

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.325.7369.891

1 reference

29 July 2017

1 reference

29 July 2017

1 reference